Major Program
Supportive Care and Symptom Management
Sponsor
University of Rochester
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT03229083
To determine if Carevive software, which monitors treatment-related toxicities and then generates self-care management plans for these symptoms, will be feasible to implement among patients with metastatic renal cell carcinoma (RCC). Additionally for collection of preliminary data on treatment-related toxicities, quality of life, distress level, and drug adherence.
Intervention
Carevive software
Condition
Advanced Renal Cell Carcinoma